Tests Catalogs
BONE MARROW TRANSPLANT FACT PANEL
LAB3474
Collect
1 - 6.0 mL Pink top
1 - 6.0 mL Purple Top
1 - 6.0 mL Red top with no gel
1 - 6.0 mL Gold with gel
Specimen Preparation
This test should ONLY be ordered on PCL patients (recipients and donors) that are preparing for a bone marrow transplant.
Performed by
Creative Test Solutions via
Bonfils Blood Center
Synonyms
- LAB3474
Performed by
Creative Test Solutions via
Bonfils Blood Center
| Collection |
LAB3474
Collect
1 - 6.0 mL Pink top
1 - 6.0 mL Purple Top
1 - 6.0 mL Red top with no gel
1 - 6.0 mL Gold with gel
Specimen Preparation
This test should ONLY be ordered on PCL patients (recipients and donors) that are preparing for a bone marrow transplant.
Performed by
Creative Test Solutions via
Bonfils Blood Center
| Ordering |
Synonyms
- LAB3474
| Result Interpretation |
Performed by
Creative Test Solutions via
Bonfils Blood Center
| Administrative |
BONE SPECIFIC ALKALINE PHOS
LAB1070
Collect
Serum separator tube. Also acceptable: Green (sodium or lithium heparin).
Specimen Preparation
Transfer 0.5 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.3 mL)
Unacceptable Conditions
Urine. Grossly hemolyzed specimens.
Storage/Transport Temperature
Frozen
Stability (from collection to initiation)
After separation from cells: Ambient: 2 hours; Refrigerated: 48 hours; Frozen: 2 months
Laboratories.Performed
Sun-Sat
Methodology
Quantitative Chemiluminescent Immunoassay
Reported
Within 24 hours
Synonyms
- Alkaline Phosphatase, Bone Specific
- LAB1070
- BSAP
Additional Technical Information
Reference Interval
Effective November 14, 2011
| Age | Male | Female |
|---|---|---|
| 6 months-2 years | 31.6- 122.6 µg/L | 33.4- 145.3 µg/L |
| 3-6 years | 31.3-103.4 µg/L | 32.9-108.6 µg/L |
| 7-9 years | 48.6-140.4 µg/L | 36.3-159.4 µg/L |
| 10-12 years | 48.8-155.5 µg/L | 44.2-163.3 µg/L |
| 13-15 years | 27.8-210.9 µg/L | 14.8-136.2 µg/L |
| 16-17 years | 15.3-126.8 µg/L | 10.5-44.8 µg/L |
| 18-24 years | 10.0- 28.8 µg/L | |
| 25 years and older | 6.5-20.1 µg/L | |
| Premenopausal Female | 4.5-16.9 µg/L | |
| Postmenopausal Female | 7.0-22.4 µg/L |
Interpretive Data
Liver alkaline phosphatase can affect the measurement of bone specific alkaline phosphatase in this assay. Each 100 U/L of liver alkaline phosphatase contributes an additional 2.5 to 5.8 µg/L to the bone specific alkaline phosphatase result.
CPT Codes
84080
| Collection |
LAB1070
Collect
Serum separator tube. Also acceptable: Green (sodium or lithium heparin).
Specimen Preparation
Transfer 0.5 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.3 mL)
Unacceptable Conditions
Urine. Grossly hemolyzed specimens.
Storage/Transport Temperature
Frozen
Stability (from collection to initiation)
After separation from cells: Ambient: 2 hours; Refrigerated: 48 hours; Frozen: 2 months
| Ordering |
Performed
Sun-Sat
Methodology
Quantitative Chemiluminescent Immunoassay
Reported
Within 24 hours
Synonyms
- Alkaline Phosphatase, Bone Specific
- LAB1070
- BSAP
Additional Technical Information
| Result Interpretation |
Reference Interval
Effective November 14, 2011
| Age | Male | Female |
|---|---|---|
| 6 months-2 years | 31.6- 122.6 µg/L | 33.4- 145.3 µg/L |
| 3-6 years | 31.3-103.4 µg/L | 32.9-108.6 µg/L |
| 7-9 years | 48.6-140.4 µg/L | 36.3-159.4 µg/L |
| 10-12 years | 48.8-155.5 µg/L | 44.2-163.3 µg/L |
| 13-15 years | 27.8-210.9 µg/L | 14.8-136.2 µg/L |
| 16-17 years | 15.3-126.8 µg/L | 10.5-44.8 µg/L |
| 18-24 years | 10.0- 28.8 µg/L | |
| 25 years and older | 6.5-20.1 µg/L | |
| Premenopausal Female | 4.5-16.9 µg/L | |
| Postmenopausal Female | 7.0-22.4 µg/L |
Interpretive Data
Liver alkaline phosphatase can affect the measurement of bone specific alkaline phosphatase in this assay. Each 100 U/L of liver alkaline phosphatase contributes an additional 2.5 to 5.8 µg/L to the bone specific alkaline phosphatase result.
| Administrative |
CPT Codes
84080
Borrelia burgdoferi Antibodies, Total w/reflex to IgG and IgM by Western Blot
LAB3222
Collect
Serum separator tube.
Specimen Preparation
Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.15 mL)
Unacceptable Conditions
CSF or plasma. Contaminated, heat-inactivated, hemolyzed, or severely lipemic specimens.
Storage/Transport Temperature
Refrigerated.
Stability (from collection to initiation)
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
Notes
This panel is appropriate for Lyme disease testing less than 4 weeks from erythema migrans or onset of disease symptoms.
A negative result indicates the immunoblot evaluation for B. burgdorferi antibody demonstrates no antibodies unique to B. burgdorferi and is, therefore, not supportive of Lyme disease.
A positive result indicates that the immunoblot evaluation for B. burgdorferi antibody is consistent with the presence of antibody produced by patients in response to infection by B. burgdorferi and suggests the presence of Lyme disease. Although the test has been shown to have a high degree of reliability for diagnostic purposes, laboratory data should always be correlated with clinical findings.
Current CDC recommendations for the serological diagnosis of Lyme disease are to screen with a polyvalent ELISA test and confirm equivocals and positives with immunoblot. Both IgM and IgG immunoblots should be performed on specimens obtained less than 4 weeks after appearance of erythema migrans. Only IgG immunoblot is to be performed on specimens greater than 4 weeks after disease onset. IgM immunoblot in the chronic stage is not recommended and does not aid in the diagnosis of neuroborreliosis or chronic Lyme disease.
If ELISA result is 1.00 LIV or greater, then IgG and IgM immunoblot will be added. Additional charges apply.
A negative result indicates the immunoblot evaluation for B. burgdorferi antibody demonstrates no antibodies unique to B. burgdorferi and is, therefore, not supportive of Lyme disease.
A positive result indicates that the immunoblot evaluation for B. burgdorferi antibody is consistent with the presence of antibody produced by patients in response to infection by B. burgdorferi and suggests the presence of Lyme disease. Although the test has been shown to have a high degree of reliability for diagnostic purposes, laboratory data should always be correlated with clinical findings.
Current CDC recommendations for the serological diagnosis of Lyme disease are to screen with a polyvalent ELISA test and confirm equivocals and positives with immunoblot. Both IgM and IgG immunoblots should be performed on specimens obtained less than 4 weeks after appearance of erythema migrans. Only IgG immunoblot is to be performed on specimens greater than 4 weeks after disease onset. IgM immunoblot in the chronic stage is not recommended and does not aid in the diagnosis of neuroborreliosis or chronic Lyme disease.
If ELISA result is 1.00 LIV or greater, then IgG and IgM immunoblot will be added. Additional charges apply.
Performed
Sun-Sat
Methodology
Semi-Quantitative Enzyme-Linked Immunosorbent Assay/Qualitative Immunoblot
Reported
1-3 days
Synonyms
- LAB3222
- LYME ACUTE
Ordering Recommendations
Preferred reflex test to detect Lyme disease in individuals with ≤4 weeks of clinical symptoms or exposure to tick. Positive/equivocal screen confirmed by immunoblot.
Reference Interval
| Components | Reference Interval | ||||||
|---|---|---|---|---|---|---|---|
| Borrelia burgdorferi Antibodies, Total by ELISA |
| ||||||
| Borrelia burgdorferi Antibody, IgG by Immunoblot | Effective August 15, 2011 Negative | ||||||
| Borrelia burgdorferi Antibody, IgM by Immunoblot | Effective August 15, 2011 Negative |
Interpretive Data
Refer to report.
CPT Codes
86618; if reflexed, add 86617 x2
| Collection |
LAB3222
Collect
Serum separator tube.
Specimen Preparation
Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.15 mL)
Unacceptable Conditions
CSF or plasma. Contaminated, heat-inactivated, hemolyzed, or severely lipemic specimens.
Storage/Transport Temperature
Refrigerated.
Stability (from collection to initiation)
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
Notes
This panel is appropriate for Lyme disease testing less than 4 weeks from erythema migrans or onset of disease symptoms.
A negative result indicates the immunoblot evaluation for B. burgdorferi antibody demonstrates no antibodies unique to B. burgdorferi and is, therefore, not supportive of Lyme disease.
A positive result indicates that the immunoblot evaluation for B. burgdorferi antibody is consistent with the presence of antibody produced by patients in response to infection by B. burgdorferi and suggests the presence of Lyme disease. Although the test has been shown to have a high degree of reliability for diagnostic purposes, laboratory data should always be correlated with clinical findings.
Current CDC recommendations for the serological diagnosis of Lyme disease are to screen with a polyvalent ELISA test and confirm equivocals and positives with immunoblot. Both IgM and IgG immunoblots should be performed on specimens obtained less than 4 weeks after appearance of erythema migrans. Only IgG immunoblot is to be performed on specimens greater than 4 weeks after disease onset. IgM immunoblot in the chronic stage is not recommended and does not aid in the diagnosis of neuroborreliosis or chronic Lyme disease.
If ELISA result is 1.00 LIV or greater, then IgG and IgM immunoblot will be added. Additional charges apply.
A negative result indicates the immunoblot evaluation for B. burgdorferi antibody demonstrates no antibodies unique to B. burgdorferi and is, therefore, not supportive of Lyme disease.
A positive result indicates that the immunoblot evaluation for B. burgdorferi antibody is consistent with the presence of antibody produced by patients in response to infection by B. burgdorferi and suggests the presence of Lyme disease. Although the test has been shown to have a high degree of reliability for diagnostic purposes, laboratory data should always be correlated with clinical findings.
Current CDC recommendations for the serological diagnosis of Lyme disease are to screen with a polyvalent ELISA test and confirm equivocals and positives with immunoblot. Both IgM and IgG immunoblots should be performed on specimens obtained less than 4 weeks after appearance of erythema migrans. Only IgG immunoblot is to be performed on specimens greater than 4 weeks after disease onset. IgM immunoblot in the chronic stage is not recommended and does not aid in the diagnosis of neuroborreliosis or chronic Lyme disease.
If ELISA result is 1.00 LIV or greater, then IgG and IgM immunoblot will be added. Additional charges apply.
| Ordering |
Performed
Sun-Sat
Methodology
Semi-Quantitative Enzyme-Linked Immunosorbent Assay/Qualitative Immunoblot
Reported
1-3 days
Synonyms
- LAB3222
- LYME ACUTE
Ordering Recommendations
Preferred reflex test to detect Lyme disease in individuals with ≤4 weeks of clinical symptoms or exposure to tick. Positive/equivocal screen confirmed by immunoblot.
| Result Interpretation |
Reference Interval
| Components | Reference Interval | ||||||
|---|---|---|---|---|---|---|---|
| Borrelia burgdorferi Antibodies, Total by ELISA |
| ||||||
| Borrelia burgdorferi Antibody, IgG by Immunoblot | Effective August 15, 2011 Negative | ||||||
| Borrelia burgdorferi Antibody, IgM by Immunoblot | Effective August 15, 2011 Negative |
Interpretive Data
Refer to report.
| Administrative |
CPT Codes
86618; if reflexed, add 86617 x2
BORRELIA BURGDORFERI BY PCR
LAB3711
Collect
Lavender (EDTA), pink (K2EDTA) or serum separator tube. OR CSF, synovial fluid or tissue.
Specimen Preparation
Separate serum or plasma from cells. Transfer 1 mL serum, plasma, CSF or synovial fluid to a sterile container. (Min: 0.5 mL). Tissue: Transfer to a sterile container and freeze immediately.
Unacceptable Conditions
Heparinized specimens.
Storage/Transport Temperature
Frozen.
Stability (from collection to initiation)
Tissue: Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 1 year
All Others: Ambient: 8 hours; Refrigerated: 72 hours; Frozen: 1 year
All Others: Ambient: 8 hours; Refrigerated: 72 hours; Frozen: 1 year
Remarks
Specimen source required.
Performed
Mon, Wed, Fri
Methodology
Qualitative Polymerase Chain Reaction
Reported
1-4 days
Synonyms
- Lyme Disease by PCR
- LAB3711
- LYMEPCR
Ordering Recommendations
Not a first-line test for Lyme disease. May be useful if strong suspicion of Lyme disease persists in spite of persistent negative serologic testing.
CPT Codes
87476
| Collection |
LAB3711
Collect
Lavender (EDTA), pink (K2EDTA) or serum separator tube. OR CSF, synovial fluid or tissue.
Specimen Preparation
Separate serum or plasma from cells. Transfer 1 mL serum, plasma, CSF or synovial fluid to a sterile container. (Min: 0.5 mL). Tissue: Transfer to a sterile container and freeze immediately.
Unacceptable Conditions
Heparinized specimens.
Storage/Transport Temperature
Frozen.
Stability (from collection to initiation)
Tissue: Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 1 year
All Others: Ambient: 8 hours; Refrigerated: 72 hours; Frozen: 1 year
All Others: Ambient: 8 hours; Refrigerated: 72 hours; Frozen: 1 year
Remarks
Specimen source required.
| Ordering |
Performed
Mon, Wed, Fri
Methodology
Qualitative Polymerase Chain Reaction
Reported
1-4 days
Synonyms
- Lyme Disease by PCR
- LAB3711
- LYMEPCR
Ordering Recommendations
Not a first-line test for Lyme disease. May be useful if strong suspicion of Lyme disease persists in spite of persistent negative serologic testing.
| Result Interpretation |
| Administrative |
CPT Codes
87476
BORRELIA HERMSII AB - IGG/IGM
LAB1205
Collect
Plain red or serum separator tube (SST).
Specimen Preparation
Transfer 1 mL serum to an ARUP Standard Transport Tube (Min: 0.25 mL)
Storage/Transport Temperature
Refrigerated. Also acceptable: Frozen.
Stability (from collection to initiation)
Ambient: 1 week; Refrigerated: 2 weeks; Frozen: 1 month
Performed
Varies
Methodology
Semi-Quantitative Indirect Fluorescent Antibody
Reported
3-11 days
Synonyms
- LAB1205
Additional Technical Information
Ordering Recommendations
Use for diagnostic workup of suspected tick-borne relapsing fever.
Reference Interval
By report
CPT Codes
86619 x2
| Collection |
LAB1205
Collect
Plain red or serum separator tube (SST).
Specimen Preparation
Transfer 1 mL serum to an ARUP Standard Transport Tube (Min: 0.25 mL)
Storage/Transport Temperature
Refrigerated. Also acceptable: Frozen.
Stability (from collection to initiation)
Ambient: 1 week; Refrigerated: 2 weeks; Frozen: 1 month
| Ordering |
Performed
Varies
Methodology
Semi-Quantitative Indirect Fluorescent Antibody
Reported
3-11 days
Synonyms
- LAB1205
Additional Technical Information
Ordering Recommendations
Use for diagnostic workup of suspected tick-borne relapsing fever.
| Result Interpretation |
Reference Interval
By report
| Administrative |
CPT Codes
86619 x2
BRUCELLA ANTIBODY (TOTAL)
LAB221
Collect
Serum separator tube.
Specimen Preparation
Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.2 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens. Mark specimens plainly as acute or convalescent.
Unacceptable Conditions
Contaminated, heat-inactivated, hemolyzed, or severely lipemic specimens.
Storage/Transport Temperature
Refrigerated.
Stability (from collection to initiation)
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 6 months (avoid repeated freeze/thaw cycles)
Performed
Mon-Fri
Methodology
Semi-Quantitative Agglutination
Reported
2-4 days
Synonyms
- LAB221
- BRUC
Ordering Recommendations
Recommended serology test to detect recent infection from Brucella in the context of a clinically compatible illness and exposure history.
Reference Interval
< 1:20 Negative
Interpretive Data
Cross-reactions may occur between Brucella and F. tularensis antigens and antisera; therefore, parallel tests should be run with these antigens. A fourfold rise in titer is considered diagnostic. A single serum titer of 1:80 or 1:160 is suggestive of brucellosis when accompanied by a compatible clinical course in a patient with a history of potential exposures.
CPT Codes
86622
| Collection |
LAB221
Collect
Serum separator tube.
Specimen Preparation
Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.2 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens. Mark specimens plainly as acute or convalescent.
Unacceptable Conditions
Contaminated, heat-inactivated, hemolyzed, or severely lipemic specimens.
Storage/Transport Temperature
Refrigerated.
Stability (from collection to initiation)
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 6 months (avoid repeated freeze/thaw cycles)
| Ordering |
Performed
Mon-Fri
Methodology
Semi-Quantitative Agglutination
Reported
2-4 days
Synonyms
- LAB221
- BRUC
Ordering Recommendations
Recommended serology test to detect recent infection from Brucella in the context of a clinically compatible illness and exposure history.
| Result Interpretation |
Reference Interval
< 1:20 Negative
Interpretive Data
Cross-reactions may occur between Brucella and F. tularensis antigens and antisera; therefore, parallel tests should be run with these antigens. A fourfold rise in titer is considered diagnostic. A single serum titer of 1:80 or 1:160 is suggestive of brucellosis when accompanied by a compatible clinical course in a patient with a history of potential exposures.
| Administrative |
CPT Codes
86622
BUFFY COAT SMEAR-MICROBIOLOGY
Collect
5 mL purple top [EDTA] top tube.
Storage/Transport Temperature
Internal: Deliver to lab immediately
Offsite: 1-3 mL purple top [EDTA] top tube. Refrigerated and transport immediately.
Offsite: 1-3 mL purple top [EDTA] top tube. Refrigerated and transport immediately.
Stability (from collection to initiation)
Room Temp: 1 hour; Refrigerated: ASAP.
Remarks
Consult with the Infectious Disease Service. Specify suspected organism. Submit promptly to the laboratory for processing.
Performed by
PCL Clinical Laboratory
Performed
Daily
Methodology
Gram Stained smears of buffy coat to look for fungal elements or intracellular bacteria.
Reported
Within 24 hours
Performed by
PCL Clinical Laboratory
CPT Codes
87205
| Collection |
Collect
5 mL purple top [EDTA] top tube.
Storage/Transport Temperature
Internal: Deliver to lab immediately
Offsite: 1-3 mL purple top [EDTA] top tube. Refrigerated and transport immediately.
Offsite: 1-3 mL purple top [EDTA] top tube. Refrigerated and transport immediately.
Stability (from collection to initiation)
Room Temp: 1 hour; Refrigerated: ASAP.
Remarks
Consult with the Infectious Disease Service. Specify suspected organism. Submit promptly to the laboratory for processing.
Performed by
PCL Clinical Laboratory
| Ordering |
Performed
Daily
Methodology
Gram Stained smears of buffy coat to look for fungal elements or intracellular bacteria.
Reported
Within 24 hours
| Result Interpretation |
Performed by
PCL Clinical Laboratory
| Administrative |
CPT Codes
87205
BUPIVACAINE
LAB3094
Collect
3 mL serum from Plain Red Top tube EDTA or Heparinized plasma [not from PST tube]
Unacceptable Conditions
Samples submitted in SST or PST tubes.
Storage/Transport Temperature
Internal: Deliver to lab immediatley
Offsite: 1.5 mL serum/plasma Ship to lab at ambient temp.
Stability (from collection to initiation)
.
Remarks
Do not use serum or plasma seprator tubes.
Performed by
National Medical Services
Performed
Varies
Methodology
Gas Chromatography
Reported
.
Synonyms
- LAB3094
Performed by
National Medical Services
CPT Codes
82491
| Collection |
LAB3094
Collect
3 mL serum from Plain Red Top tube EDTA or Heparinized plasma [not from PST tube]
Unacceptable Conditions
Samples submitted in SST or PST tubes.
Storage/Transport Temperature
Internal: Deliver to lab immediatley
Offsite: 1.5 mL serum/plasma Ship to lab at ambient temp.
Stability (from collection to initiation)
.
Remarks
Do not use serum or plasma seprator tubes.
Performed by
National Medical Services
| Ordering |
Performed
Varies
Methodology
Gas Chromatography
Reported
.
Synonyms
- LAB3094
| Result Interpretation |
Performed by
National Medical Services
| Administrative |
CPT Codes
82491